Health Care Fraud Defense and Compliance Counseling
Financial Services Litigation & Regulation
Strategic Discovery & Information Management
T: (212) 880-3582
F: (212) 880-3998
T: (202) 661-7022
F: (202) 661-7059
For more information visit Our Team page.
We believe that health care fraud will continue to be one of the most active sectors of the U.S. Department of Justice’s overall fraud enforcement programs. Federal and state regulators will continue to aggressively pursue fraud and abuse in False Claims Act matters, anti-kickback violations and patient privacy issues. We saw in September 2020 that the DOJ had one of the largest takedowns in history that targeted, among others, fraud and abuse in the telemedicine and prescription drug industries. We anticipate that as a result of the COVID-19 pandemic, under the Biden Administration, the DOJ and HHS will increase their focus on fraud and abuse in telehealth services that had expanded greatly in response to the coronavirus crisis. Providers and other individuals and entities who provide telehealth supplies and/or services are encouraged to consult their legal counsel to ensure that their policies and procedures will not trigger regulatory or law enforcement scrutiny.